Lemtrada 10 mg/ml, solution à diluer pour perfusion

7680630250018 CH-63025 Lösung
Lemtrada 10 mg/ml, solution à diluer pour perfusion
Lemtrada 10 mg/ml, solution à diluer pour perfusion
Lemtrada 10 mg/ml, solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/07/2024
Patient information leaflet
Français
30/07/2024
Patient information leaflet
Italien
30/07/2024
Summary of Product Characteristics
Allemand
30/07/2024
Summary of Product Characteristics
Français
30/07/2024
Summary of Product Characteristics
Italien
30/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
12.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.26 MG Substance HBESI
(N/A)
0.19 MG Substance HBESI

Reimbursement information

Public price
CHF 7223.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2015

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
63025
Drug name
Lemtrada, solution à diluer pour perfusion
Galenic form
KOINF
ATC Code
L04AA34
Authorization status
Z
Dispensing category
A
First authorization
16/12/2014
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
LEMTRADA conc perf 12 mg/1.2ml flac
Description (DE)
LEMTRADA Inf Konz 12 mg/1.2ml Durchstf
Market launch
16/12/2014
Narcotic (BTM)
No